Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention

被引:79
作者
Goldberg, Ronald B. [1 ]
Temprosa, Marinella [1 ]
Haffner, Steven [1 ]
Orchard, Trevor J. [1 ]
Ratner, Robert E. [1 ]
Fowler, Sarah E. [1 ]
Mather, Kieren [1 ]
Marcovina, Santica [1 ]
Saudek, Chris [1 ]
Matulik, Margaret J. [1 ]
Price, David [1 ]
机构
[1] George Washington Univ, Diabet Prevent Program Coordinating Ctr, Rockville, MD USA
基金
美国国家卫生研究院;
关键词
CORONARY-HEART-DISEASE;
D O I
10.2337/dc08-0494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Although subjects with diabetes have increased risk for cardiovascular disease (CVD), the evolution of this increased risk as pre-diabetic individuals progress to diabetes is not understood. This study examines the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program. RESEARCH DESIGN AND METHODS - A total of 3,234 participants with impaired glucose tolerance (IGT) were followed for a mean of 3.2 years after randomization to intensive lifestyle intervention (ILS), metformin, or placebo. Using repeated-measures models, adjusted mean levels of risk factors were estimated for an annual change in glycemic status. Tests were also conducted to assess the risk factor trends with improvement or worsening of glycemic status. RESULTS - CVD risk factor values and changes from baseline became snore unfavorable as glucose tolerance status deteriorated but improved with reversion to normal glucose tolerance (NGT), especially in the ILS intervention group (trend test P < 0.001 for all risk factors except for LDL PPD [P = 0.02] in ILS and HDL cholesterol [P = 0.02] in placebo). Although there were few significant differences in the transition from IGT to diabetes, there were strong relationships between risk factors and continuous treasures of glycemia. CONCLUSIONS - Progression from IGT to diabetes is associated with mild deterioration, whereas reversion to NGT is associated with improvement in risk factors. Early intervention with ILS, but less so with metformin, in participants at high risk for diabetes improves the cardiovascular risk and glucose tolerance profile simultaneously.
引用
收藏
页码:726 / 732
页数:7
相关论文
共 21 条
[11]   Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects -: Implications for preventing coronary heart disease during the prediabetic state [J].
Haffner, SM ;
Mykkänen, L ;
Festa, A ;
Burke, JP ;
Stern, MP .
CIRCULATION, 2000, 101 (09) :975-980
[12]   CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898
[13]  
HOKANSON JE, 1997, HDB LIPOPROTEIN TEST, P267
[14]  
Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404
[15]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[16]   Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance - The Framingham Offspring Study [J].
Meigs, JB ;
Nathan, DM ;
Wilson, PWF ;
Cupples, LA ;
Singer, DE .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) :524-+
[17]  
Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888
[18]   Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? [J].
Stern, MP ;
Williams, K ;
Haffner, SA .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) :575-581
[19]   Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study [J].
Stratton, IM ;
Adler, AI ;
Neil, HAW ;
Matthews, DR ;
Manley, SE ;
Cull, CA ;
Hadden, D ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :405-412
[20]  
Warnick G R, 1986, Methods Enzymol, V129, P101